CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects (Q47961774)

7 February 2018

title

CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects (English)

1 reference

7 February 2018

1 reference

14

1 reference

7 February 2018

Agus Salim

object named as

Agus Salim

13

0 references

Mark Richards

12

object named as

Mark A Richards

1 reference

7 February 2018

author name string

Mark Y Chan

1

1 reference

7 February 2018

Karen Tan

2

1 reference

7 February 2018

Huay-Cheem Tan

3

1 reference

7 February 2018

Pei-Tee Huan

4

1 reference

7 February 2018

Bei Li

5

1 reference

7 February 2018

Qian-Hui Phua

6

1 reference

7 February 2018

Hong-Kai Lee

7

1 reference

7 February 2018

Chi-Hang Lee

8

1 reference

7 February 2018

Adrian Low

9

1 reference

7 February 2018

Richard C Becker

10

1 reference

7 February 2018

Wen-Chong Ong

11

1 reference

7 February 2018

Evelyn Koay

15

1 reference

7 February 2018

publication date

1 April 2012

1 reference

7 February 2018

published in

Pharmacogenomics

1 reference

7 February 2018

volume

13

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

533-542

1 reference

7 February 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

cites work

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

Genotyping: one piece of the puzzle to personalize antiplatelet therapy

21 January 2018

1 reference

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

21 January 2018

1 reference

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

21 January 2018

1 reference

Allele and genotype frequency of CYP2C19 in a Tamilian population

21 January 2018

1 reference

Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy

21 January 2018

1 reference

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

21 January 2018

1 reference

Genetic variations and haplotypes of CYP2C19 in a Japanese population

21 January 2018

1 reference

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

21 January 2018

1 reference

The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome.

21 January 2018

1 reference

The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance

21 January 2018

1 reference

Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism

21 January 2018

1 reference

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement

21 January 2018

1 reference

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

21 January 2018

1 reference

Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.

21 January 2018

1 reference

Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations--a short review.

21 January 2018

1 reference

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

21 January 2018

1 reference

Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.12.24

1 reference

7 February 2018

release_ecwa5lfsjza4dj3zrrmvk2v2ym

Fatcat ID

0 references

1 reference

7 February 2018